T. Rowe Price Associates
EIDX

T. Rowe Price Associates’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

T. Rowe Price Associates’s Portfolio EIDX Stock Details EIDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-211,102
Closed -$27.8M – 2892
2020
Q4 		$27.8M Buy
211,102
+345
+0.2% +$45.4K ﹤0.01% 1129
2020
Q3 		$10.7M Sell
210,757
-25,393
-11% -$1.28M ﹤0.01% 1289
2020
Q2 		$11.3M Buy
+236,150
New +$11.3M ﹤0.01% 1269